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E-mail address: rxx@case.edu (R. Xu).An important task in pharmacogenomics (PGx) studies is to identify genetic variants that may impact
drug response. The success of many systematic and integrative computational approaches for PGx studies
depends on the availability of accurate, comprehensive and machine understandable drug–gene relation-
ship knowledge bases. Scientiﬁc literature is one of the most comprehensive knowledge sources for
PGx-speciﬁc drug–gene relationships. However, the major barrier in accessing this information is that
the knowledge is buried in a large amount of free text with limited machine understandability. Therefore
there is a need to develop automatic approaches to extract structured PGx-speciﬁc drug–gene relation-
ships from unstructured free text literature. In this study, we have developed a conditional relationship
extraction approach to extract PGx-speciﬁc drug–gene pairs from 20 million MEDLINE abstracts using
known drug–gene pairs as prior knowledge. We have demonstrated that the conditional drug–gene rela-
tionship extraction approach signiﬁcantly improves the precision and F1 measure compared to the
unconditioned approach (precision: 0.345 vs. 0.11; recall: 0.481 vs. 1.00; F1: 0.402 vs. 0.201). In this
study, a method based on co-occurrence is used as the underlying relationship extraction method for
its simplicity. It can be replaced by or combined with more advanced methods such as machine learning
or natural language processing approaches to further improve the performance of the drug–gene rela-
tionship extraction from free text. Our method is not limited to extracting a drug–gene relationship; it
can be generalized to extract other types of relationships when related background knowledge bases
exist.
 2012 Elsevier Inc. All rights reserved.1. Introduction
Automatically extracting pharmacogenomics (PGx) speciﬁc
drug–gene pairs from free text is a challenging task. First, gene sym-
bols are short and sometimes ambiguous. Ambiguous gene symbols
can introduce false positives during the relationship extraction pro-
cess. For instance, the symbol ‘‘CAD’’ can represent the gene symbol
for ‘‘carbamoyl-phosphate synthetase 2, aspartate transcarbamylase,
and dihydroorotase’’. ‘‘CAD’’ is also the symbol for a metabolizing
gene for the pharmacological substance l-glutamine. In addition, ‘‘
CAD’’ is the abbreviation for ‘‘coronary artery disease’’ in MEDLINE
and co-occurs with many drugs indicated for cardiovascular dis-
eases. When ‘‘CAD’’ co-occurs with a drug, the relationship can be
a PGx-speciﬁc drug–gene relationship (e.g., l-glutamine-CAD and
aspartate-CAD), or drug disease relationship (e.g., cyclosporine-CAD,
azathioprine-CAD and prednisone-CAD). Secondarily, the exact
semantic relationships between a drug and its co-occurred genes
can be a drug–gene target relationship (e.g., enalapril-ACE, andll rights reserved.testosterone-AR), metabolizing (PGx) relationship (e.g., warfarin-
CYP2C9, and warfarin-VKORC1) or others. For accurate PGx-speciﬁc
drug–gene relationship extraction from free text, it is important to
disambiguate gene symbols or semantically classify sentences
before extracting the drug–gene relationship from sentences.
Standard drug–gene relationship extraction algorithms often
use natural language processing (NLP), machine learning, co-occur-
rence statistics, or a combination of these methods to extract drug–
gene pairs from sentences (Fig. 1a). Unlike standard methods, our
conditional methods only extract drug–gene pairs from sentences
classiﬁed as PGx-related (Fig. 1b). More speciﬁcally, we ﬁrst auto-
matically classify sentences as PGx-related or not based on the
occurrences of known PGx-speciﬁc drug–gene pairs or PGx-speciﬁc
genes in the sentences. Then, we extract additional drug–gene
pairs from the sentences classiﬁed as PGx-related using standard
relationship extraction approaches (co-occurrence methods used
in this study). For example, the sentence ‘‘Substrates for CYP2C9
include ﬂuoxetine, losartan, phenytoin, tolbutamide, torsemide,
S-warfarin, and numerous NSAIDs’’ (PMID 09663807) contains a
known PGx-speciﬁc drug–gene pair warfarin-CYP2C9 and is classi-
ﬁed as PGx-related. Additional drug–gene pairs, such as ﬂuoxetine-
Fig. 1. (a) Standard and (b) conditional PGx-speciﬁc drug–gene relationship extraction methods.
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and torsemide-CYP2C9, will be extracted from this sentence and
determined to be PGx-speciﬁc.
2. Background
2.1. Importance of PGx-speciﬁc drug–gene relationship extraction from
free text
Different patients respond differently to the same drug. Both
genetic and non-genetic factors are involved in an individual’s drug
response, with genetics accounting for 20–95% of variability [1].
Pharmacogenomics (PGx) is the study of how human genetic vari-
ations affect an individual’s response to drugs, with focuses on
drug metabolism, absorption, distribution and excretion. The
assumption underlying personalized medicine is that an individ-
ual’s genotype proﬁle can be used to predict effects (both efﬁcacy
and side effects) of drug treatment [2]. An understanding of the ge-
netic variants associated with various drug responses is an essen-
tial step of personalized medicine [3,4].
New PGx discovery depends on knowledge generated by previ-
ous research. PGx research is a knowledge-intensive ﬁeld whose
goal is to discover new drug–gene relationship knowledge and
put it to clinical use for disease treatment. In this ﬁeld, the research
focus is rapidly shifting from studying an individual entity (e.g., one
disease, drug, or gene) to entire networks of many different biolog-
ical entities. Computational analysis of the knowledge represented
in biomedical networks can uncover important new relationships,
generate new testable hypotheses and provide new insight into bio-
logical systems [5,6]. Recent investigations use systems biology
methods to examine drug responses, by utilizing a network-based
view of the genes involved in complex drug responses [7,8].
The success of PGx studies largely depends on the availability of
accurate, comprehensive and machine understandable drug–gene
relationship knowledge. Adequate drug–gene relationship acquisi-
tion and integration are therefore becoming fundamentally impor-
tant for these studies. The number of biomedical research
publications, and therefore the underlying biomedical knowledge
base, is rapidly expanding. The MEDLINE 2010 database contains
over 20 million records (http://www.ncbi.nlm.nih.gov/pubmed).
Scientiﬁc literature is the ultimate knowledge source for PGx stud-
ies. Clearly, with the current rate of growth in published biomedi-
cal research, it becomes increasingly likely that important
knowledge connecting drugs, genes and diseases is being missed.
There is a need to develop new ways to acquire structured
drug–gene relationship knowledge from literature. Biocuration isthe activity of transforming the information buried in human nat-
ural language into machine understandable knowledge by human
curators reading scientiﬁc reports and extracting knowledge from
published literature [9]. Biocuration has become an essential part
of biological discovery and biomedical research. Substantial man-
ual curation efforts have been used to extract PGx knowledge from
literature. For example, The Pharmacogenomics Knowledge Base
(PharmGKB) is an integrated resource about how variation in hu-
man genetics leads to variation in response to drugs [10]. Each of
the curation projects involves a large number of curators, but their
knowledge base is still limited by their ability to review all current
related medical literature in a timely manner. To extract biomedi-
cal information, including drug–gene relationships, from published
literature manually and to transform it into machine understand-
able knowledge is a difﬁcult task, since biomedical terminologies
and knowledge are huge, dynamic, diversiﬁed and complex. In
addition, human curators are liable to error and subjective bias.
Therefore, any manually curated terminology and knowledge base
is deemed to be incomplete [11,12]. Automated information
extraction of structured knowledge from natural language text is
crucial to biomedical researchers in their search for complete and
up-to-date knowledge from published scientiﬁc reports. Compared
to potential biocurator errors generated by heavy workload and/or
bias, automated extraction will improve the quality and timeliness
of the knowledge base.
2.2. Methods for biomedical relationship extraction from free text
Currently there are twomajor types of approaches for extracting
biomedical relationships, including drug–gene relationships, from
free text. The simplest and also the most widely used approaches
are based on co-occurrence and use frequency-based statistics to
rank extracted relationships. Li et al. used the co-occurrence of drug
and disease names in MEDLINE abstracts to derive drug–disease
relationships and to build a disease speciﬁc drug–protein network
[13]. Yen et al. developed a co-occurrence approach based on an
information retrieval principle to extract gene–disease relationships
from text [14]. Blaschke et al. and Rosario et al. extracted semantic
relationships among entities based on co-occurrence of two named
entities and one semantic type from text [15,16]. The assumption of
co-occurrence methods is that, if two entities appear together, they
maybe related. Co-occurrencemethods oftenhavehigh recall. How-
ever, it is often true that two entities are mentioned together with-
out being semantically related [17]. Therefore, an important
shortcoming of these methods is that they introduce many false
positives and suffer low precision. In addition, no semantics are
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extraction algorithm is based on NLP techniques to recognize enti-
ties and relationships using domain-speciﬁc lexicons and syntactic
grammars. Syntactic templates and shallow parsing are often used
in these NLP-based approaches. NLP methods have the advantage
of being able to learn semantic types between entities. However,
NLP methods sometimes suffer from low recall [18]. Rindﬂesch
et al. extracted protein-binding relationships from text using NLP
methods [19]. Leroy et al. have developed a shallow parser based
on closed-class words to capture a variety of relationships from text
[20]. Friedman et al. developed an NLP system called GENIE to ex-
tract molecular pathways from journal articles [21]. Rindﬂesh
et al. developed a rule-based symbolic natural language processing
system called SemRep to extract semantic predications from free
text using the Uniﬁed Medical Language System (UMLS)] as the
underlyingknowledgebase [22,23]. However, due to the complexity
of natural language, these NLP-based relationship extraction
methods often target only speciﬁc semantic relations.
2.3. Prior studies of PGx-speciﬁc drug–gene relationship extraction
from free text
Developing automatic approaches for extraction of PGx-speciﬁc
drug–gene relationships from free text is a highly active research
area. Both co-occurrence and NLP methods have been used. Chang
et al. extracted drug–gene pairs from literature using the co-occur-
rence method and then used supervised machine learning algo-
rithms to classify the extracted relationships into ﬁve
subcategories such as genotype, clinical outcome, or pharmacoki-
netics [24]. The co-occurrence algorithmwas able to achieve a recall
of 78% when evaluated using one review article from the literature.
However, the precision was not reported in Chang’s study. Garten
et al. developed Pharmspresso, a text-mining tool for extracting
PGx concepts and relationships from full text [25]. The evaluation
in Garten’s studywas done usingmanually curated PGx related arti-
cles, and the performance of extracting drug–gene relationships
from other types of text (e.g., general MEDLINE articles) was not
evaluated. Guided by the drug–gene relationships available in Phar-
mGKB, Theobald et al. constructed n-way Bayesian networks based
on conditional probability tables extracted from co-occurrence sta-
tistics over the entireMEDLINEcorpus, andproduceda broad-cover-
age analysis of the relationships between these biological entities
[26]. The focus of Theobald’s study was on building a Bayesian net-
work. No evaluationwas done in terms of the precision and recall of
the extracted drug–gene relationships. Hansen et al. recently de-
scribed an algorithm that uses existing knowledge to rank 12,460
genes in the human genome on the basis of their potential relevance
to speciﬁc drugs [7]. Strictly speaking, this work did not focus on
developing automatic methods for drug–gene relationship extrac-
tion from free text; it used existing biomedical knowledge about
drug structures and indications in order to improve the precision
of ranking PGx-speciﬁc genes for a givendrug. Garten et al. extended
Hansen’s work by replacing the drug–gene relationships in Phar-
mGKB with the drug–gene co-occurrence relationships extracted
from manually curated PGx-speciﬁc full-text articles [27] and
showed that a knowledgebase derived fromco-occurrence relation-
ships mined from PGx speciﬁc literature performs as well as the cu-
rated knowledge base. Although the focus of these two studies was
not on automatic drug–gene relationship extraction from free text,
they demonstrate that prior knowledge is important for PGx-spe-
ciﬁc drug–gene relationship determination and that drug–gene co-
occurrences based on highly relevant PGx literature have quality
comparable to those curated by humans. Ahlers et al. developed
anNLP system(EnhancedSemRep) to extract semantic relationships
on pharmacogenomics in Medline citations [28]. The development
of Enhanced SemRep depends on domain knowledge in the UMLS.Coulet et al. have developed NLP techniques to build a PGx ontology
from 17 million MEDLINE abstracts by using the syntactic depen-
dency structure of MEDLINE sentences to systematically extract
common relationships and to map them to a common schema
[29]. This method, based on detailed syntactic dependency analysis,
achieved high precision. Recall was not reported.2.4. Special challenges in PGx-speciﬁc drug–gene relationship
extraction from free text and our approach
As we discussed in Section 1, extracting PGx-speciﬁc drug–gene
relationships from free text is a challenging task. First, gene sym-
bols are sometimes ambiguous. For instance, the symbol ‘‘CAD’’
represents the metabolizing gene ‘‘carbamoyl-phosphate synthetase
2, aspartate transcarbamylase, and dihydroorotase’’. ‘‘CAD’’ is also the
abbreviation used for ‘‘coronary artery disease’’. When a drug name
co-occurs with the symbol ‘‘CAD’’, the relationship can be a drug–
gene relationship as shown in sentence (1), or a drug–disease rela-
tionship as shown in sentence (2).
(1) ‘‘Mammalian DHOase (S-dihydroorotate amidohydrolase, EC
3.5.2.3) is part of a large multifunctional protein called CAD,
which also has a carbamoyl-phosphate synthetase [carbon-
dioxide: L-glutamine amido-ligase (ADP-forming, carbamate-
phosphorylating), EC 6.3.5.5] and aspartate transcarbamoylase
(carbamoyl-phosphate: L-aspartate carbamoyltransferase, EC
2.1.3.2) activities’’ (PMID 01967494).
(2) ‘‘The possible role of viral infection in the genesis of CAD stim-
ulated the review of 102 patients transplanted since the intro-
duction of triple drug immunosuppression (cyclosporine,
azathioprine and prednisone) to assess the importance of
posttransplant cytomegalovirus infection in the development
of CAD in the cardiac graft’’ (PMID 02547298)
For accurate drug–gene relationship extraction, it is necessary
to disambiguate gene symbols or classify sentences based on the
features or prior knowledge inherent in the sentences. In this
study, we ﬁrst automatically classify sentences as PGx-related or
non-PGX-related, based on the occurrences of known PGx-speciﬁc
drug–gene pairs in the sentences. Then, we extract additional
drug–gene pairs from the sentences classiﬁed as PGx-related. For
example, sentence (1) contains one known PGx-speciﬁc drug–gene
pair CAD-L-aspartate, and is classiﬁed as PGx-related. An additional
drug–gene pair CAD-L-glutamine is extracted from sentence (1) if
this pair is unknown. On the other hand, sentence (2) does not con-
tain any known PGx-speciﬁc drug–gene pairs and is classiﬁed as
non-PGX-related. Thus, no drug–gene relationship extraction is
performed for sentence (2).
Secondarily, even though a gene is drug-related, the exact
semantic relationships between the gene and co-occurred drugs
can be complicated. The semantic relationships between a drug
and a gene can be a drug–gene target relationship as shown in sen-
tences (3) and (4), or a drug–gene metabolizing relationship as
shown in sentences (5) and (6).
(1) ‘‘AR agonists and inhibitors included dihydrotestosterone
(DHT), testosterone (T), and ﬂutamide (Flu)’’ (PMID
17559882).
(2) ‘‘ACE inhibitors: enalapril and captopril compared’’ (PMID
02998719).
(3) ‘‘Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for
warfarin’’ (PMID 18281922).
(4) ‘‘Substrates for CYP2C9 include ﬂuoxetine, losartan, phenyt-
oin, tolbutamide, torsemide, S-warfarin, and numerous NSA-
IDs’’ (PMID 09663807).
Table 1
PharmGKB drug–gene pair occurrence in MEDLINE.
Drugs Genes Drug–gene pairs
PharmGKB 918 2388 10,898
PharmGKB in MEDLINE sentences 585 718 2943
PharmGKB in MEDLINE abstracts 643 965 3957
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relationship knowledge to classify sentences, and then extracted
drug–gene pairs from PGx-related sentences. For example, neither
sentence (3) nor (4) contains known PGx-speciﬁc drug–gene pairs,
and our algorithm will classify these two sentences as non-PGx-re-
lated. Sentence (5) contains a known PGx-speciﬁc drug–gene pair
warfarin-CYP2C9 and will be classiﬁed as PGx-related. An
additional drug–gene pair warfarin-VKORC1 will be extracted from
sentence (5) if this pair is unknown. Similarly, sentence (6) will be
classiﬁed as PGx-related based on the occurrence of a known drug–
gene pair warfarin-CYP2C9. Additional PGx-speciﬁc drug–gene
pairs such as ﬂuoxetine-CYP2C9, losartan-CYP2C9, phenytoin-
CYP2C9, tolbutamide-CYP2C9, and torsemide-CYP2C9 will be
extracted from this sentence.
The focus of our study is not to develop an independent drug–
gene relationship extraction algorithm. Instead, our goal is to dem-
onstrate that drug–gene relationship extraction algorithms can
beneﬁt from the addition of existing prior knowledge. The main
contribution of this study is that we use prior knowledge, i.e., the
known drug–gene pairs available in PharmGKB, to classify sen-
tences as PGx-related or non-PGx-related before applying any
drug–gene relationship extraction algorithms. Our assumption is
that if a sentence contains one known PGx-speciﬁc drug–gene pair,
it is very likely that this sentence is a PGx-related sentence. Then
additional drug–gene pairs extracted from PGx-related sentences
are likely to be PGx-speciﬁc drug–gene pairs. In this study we
use co-occurrence based on a relationship extraction algorithm
for its simplicity. However, the co-occurrence based method can
be easily replaced by more advanced methods such as machine
learning, NLP or rule-based approaches.3. Data and methods
We have used 20 million MEDLINE abstracts (roughly 100 mil-
lion sentences) published from 1965 to 2010 as the text corpus
for our task of PGx-speciﬁc drug–gene relationship extraction.
The drug–gene pairs available in PharmGKB were used as prior
knowledge and as an evaluation gold standard. The PharmGKB
database, downloaded in January of 2011, contained 10,898
drug–gene pairs, 918 drugs, and 2388 genes. Annotation of the
20 million MEDLINE abstracts and 100 million sentences with
drugs and gene terms was done using ThinTek’s high performance
tagger (http://www.thintek.com/). ThinTek’s tagger is a cloud-
based fast general-purpose biomedical named entity recognizer
running on multiple processors in parallel. The tagger is based on
simple exact string matching; no syntactic parsing was used. The
tagger takes as input either user-provided biomedical dictionaries
or the biomedical dictionaries that ThinTek provides. In this study,
we provided the tagger the lists of drug and gene terms from Phar-
mGKB. For each MEDLINE sentence or abstract, we collected the
co-occurring drug–gene pairs.
There are total 918 drugs, 2388 genes and 10,898 drug–gene
pairs in PharmGKB. Only 2943 (27%) out of the 10,898 pairs appear
in MEDLINE sentences, 3957 (36%) pairs appear in MEDLINE ab-
stracts, and 1014 pairs appear in MEDLINE abstracts, but not in
sentences since a drug and gene can occur in the same abstract
but be in different sentences (Table 1). This overall low percentage
is partly due to the fact that the drug terms in PharmGKB drug–gene
relationships include drug class names such as anticholinesterases,
antihypertensives, antimalarials and beta blocking agents, and non-
natural language drug names such as ‘‘antivirals for treatment of
HIV infections, combinations’’, ‘‘sulfonamides, urea derivatives’’, ‘‘anti-
inﬂammatory and antirheumatic products, non-steroids’’, ‘‘multivita-
mins, plain’’, and ‘‘interferon alfa-2a, recombinant’’. These terms are
not commonly used in MEDLINE research articles. To evaluateMEDLINE-based PGx-speciﬁc drug–gene relationship extraction
algorithms, we used the PharmGKB drug–gene pairs that appear
in MEDLINE as the gold standard. We used the 2943 drug–gene
pairs that occur in MEDLINE sentences as the gold standard to eval-
uate drug–gene relationship extraction from sentences, and the
3957 pairs that appear in MEDLINE abstracts were used as the gold
standard for evaluating relationship extraction from MEDLINE
abstracts.
We developed two methods to extract PGx-speciﬁc drug–gene
pairs from MEDLINE sentences. The algorithm ‘‘Unconditioned’’ is
a simple co-occurrence based method in which drug–gene pairs
are extracted from unclassiﬁed sentences (Fig. 2a). The algorithm
‘‘Drug–Gene Conditioned’’ ﬁrst classiﬁes sentences based on the
occurrence of known drug–gene pairs from PharmGKB before rela-
tionship extraction (Fig. 2b). The drug–gene pairs in PharmGKB are
split into two parts: one part is used as training data set in the algo-
rithm ‘‘Drug–Gene Conditioned’’, but not used in the algorithm
‘‘Unconditioned’’), and the other part is used as testing data. The
same testing data was used for both methods. The Student’s t-test
was performed for signiﬁcance evaluation. A comparison evalua-
tion was determined as signiﬁcant when p value is less than 10E7.4. Results
4.1. Performance comparison of the unconditional and conditional
methods for PGx-speciﬁc drug–gene relationship extraction from
MEDLINE
We compared the precision, recall and F1 measure of the two
co-occurrence based approaches (‘‘Unconditioned’’ vs. ‘‘Drug–Gene
Conditioned’’) for PGx-speciﬁc drug–gene pair extraction from
both MEDLINE sentences and abstracts. The ‘‘Unconditioned’’
method is a simple co-occurrence based method for drug–gene
extraction from unclassiﬁed MEDLINE sentences or abstracts. The
‘‘Drug–Gene Conditioned’’ method uses the occurrence of known
drug–gene pairs to classify sentences as PGx-related or not before
relationship extraction. The drug–gene pairs from PharmGKB were
randomly split into training data set and testing data set at ﬁve dif-
ferent training/testing ratios: 10–90%, 20–80%, 30–70%, 40–60%,
and 50–50%. One part (training set) was used as the prior knowl-
edge for classifying sentences in the method ‘‘Drug–Gene Condi-
tioned’’, but not used in the method ‘‘Unconditioned’’. The other
part (testing set) was used for evaluation for both methods.
As shown in Table 2, the method ‘‘Drug–Gene Conditioned’’ sim-
ilar consistently has signiﬁcantly better precision and F1 values
than the ‘‘Unconditioned’’ method. These improvements were
similar signiﬁcant for both sentence-based and abstract-based
drug–gene pair extraction at all ﬁve different training/test ratios
(The p-values are all less than 10E–7). For example, when 10% of
PharmGKB drug–gene pairs (294 out of the 2943 pairs that appear
in MEDLINE sentences) were used as prior knowledge for sentence
classiﬁcation, and the remaining 90% were used as testing data, the
method ‘‘Drug–Gene Conditioned’’ achieved a precision value of
38.8%, more than a 200% improvement over the Unconditioned
method (precision: 11.7%). The recall is lower for the method
‘‘Drug–Gene Conditioned’’, but the F1 score, which is the balanced
measure of precision and recall, is signiﬁcantly higher (37.7% vs.
Fig. 2. (a) Unconditional co-occurrence method for drug–gene relationship extraction from unclassiﬁed sentences; (b) Conditional co-occurrence (‘‘Drug–Gene Conditioned’’)
method for PGx-speciﬁc drug–gene relationship extraction from classiﬁed sentences containing known PGx-speciﬁc drug–gene pairs.
Table 2
Performance comparison of ‘‘Unconditioned’’ and ‘‘Drug–Gene Conditioned’’ PGx-speciﬁc drug–gene relationship extractions from MEDLINE sentences and abstracts.
PharmGKB Unconditioned Drug–Gene conditioned
Prior (%) Testing (%) Precision Recall F1 Precision Recall F1
10 90 11.7 100.0 20.9 38.8 36.6 37.7
20 80 11.1 100.0 20.1 34.5 48.1 40.2
Sentence 30 70 10.5 100.0 18.9 30.8 55.5 39.7
40 60 10.0 100.0 18.1 28.4 60.2 38.5
50 50 9.1 100.0 16.7 24.9 65.1 36.1
10 90 8.1 100.0 14.9 26.8 50.5 35.0
20 80 7.6 100.0 14.1 21.7 64.3 32.4
Abstract 30 70 7.2 100.0 13.4 18.4 70.8 29.2
40 60 6.8 100.0 12.7 16.4 74.7 26.9
50 50 6.4 100.0 12.0 14.8 78.8 24.9
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document types (sentences or abstracts) and not sensitive to the
amount of prior knowledge and testing data used. For the ‘‘Uncon-
ditioned’’ method, the precision slightly decreased from 11.7% to
9.1% when testing data was decreased from 90% to 50%. For the
‘‘Drug–Gene Conditioned’’ method, the precision also signiﬁcantly
decreased from 38.8% to 24.9% when less test data was used, while
recall signiﬁcantly increased from 36.6% to 65.1% and F1 did not
change (37.1–36.1%). However, the ‘‘Drug–Gene Conditioned’’
method has signiﬁcantly better precision and F1 than the ‘‘Uncon-
ditioned’’ method, even when the amount of testing data was de-
creased. In addition, both the ‘‘Unconditioned’’ and ‘‘Drug–Gene
Conditioned’’ methods for drug–gene relationship extraction from
sentences consistently has signiﬁcantly better precision and F1
scores than from abstracts. (p-values are less than 10E7).
These results show that using known drug–gene relationship
knowledge to guide drug–gene relationship extraction from free
text can signiﬁcantly reduce false positives while keeping high re-
call. Theoccurrenceof aknownPGx-speciﬁcdrug–genepair in a sen-
tence or abstract can implicitly classify the sentence or abstract as
PGx-related. Drug–gene relationship extraction from sentences or
abstracts classiﬁed as PGx-related has signiﬁcantly better precision
and F1 scores than from unclassiﬁed sentences. In this study, we
used the simple co-occurrence-based relationship extraction meth-
od, which can be easily replaced bymore advancedmethods such as
NLP andmachine learningmethods.We expect that these advanced
methods will beneﬁt from extraction from PGx-related sentences.
4.2. Comparison of different conditional methods for PGx-speciﬁc
drug–gene extraction
We have shown that the occurrence of known PGx-speciﬁc
drug–gene pairs in a sentence or abstract can implicitly classifythe sentence or abstract as PGx-related and therefore improve
the overall precision and F1 of subsequent drug–gene relationship
extraction (Table 2). We then tested whether or not the appearance
of additional drug terms, gene terms or both (not necessarily
known PGx-speciﬁc drug–gene pairs) can also implicitly classify
a sentence or abstract as PGx-related. We have developed ﬁve dif-
ferent PGx-speciﬁc drug–gene extraction methods: (1) The
‘‘Unconditioned’’ method extracts drug–gene pairs from unclassi-
ﬁed sentences, (2) The ‘‘Drug–Gene Conditioned’’ method extracts
drug–gene pairs only from sentences containing known PGx-spe-
ciﬁc drug–gene pairs, (3) The ‘‘Drug Conditioned’’ method per-
forms relationship extraction only from sentences that contain at
least one additional drug term, (4) The ‘‘Gene Conditioned’’ method
performs relationship extraction only from sentences that contain
at least one additional gene, and (5) The ‘‘Drug  Gene Condi-
tioned’’ method extracts drug–gene pairs only from sentences con-
taining at least one additional drug term and one gene term. The
method ‘‘Drug–Gene Conditioned’’ is conditioned on the appear-
ance of actual drug–gene pairs from PharmGKB while the method
‘‘Drug  Gene Conditioned’’ is conditioned on the appearance of
the cross product of genes and drugs from PharmGKB. We split
the drug–gene pairs in PharmGKB into training data set and testing
data set. We use the drug terms, gene terms, or drug–gene pairs in
the training data set to implicitly classify sentences before rela-
tionship extraction for conditioned methods. For example, when
we use a randomly selected 10% of PharmGKB drug–gene pairs
as training data set, we obtain 294 known drug–gene pairs, 189
drugs, 158 genes, and total of 29,862 (189  158) drug–gene pairs.
In the ‘‘Drug–Gene Conditioned’’ method, a sentence is classiﬁed as
positive if it contains at least one of the 294 known drug–gene
pairs. In the ‘‘Gene Conditioned’’ method, a sentence is classiﬁed
as positive when it contains at least one of the 158 genes. In the
‘‘Drug  Gene Conditioned’’ method, a sentence is determined as
Table 3
Comparison of ﬁve different methods: ‘‘Unconditioned’’, ‘‘Drug–Gene Conditioned’’, ‘‘Drug Conditioned’’, ‘‘Gene Conditioned’’, and ‘‘Drug  Gene Conditioned’’.
Condition Training (%) Testing Precision Recall F1
Sentence Unconditioned 10 90 11.7 100.0 20.9
50 50 9.1 100.0 16.7
Drug–Gene conditioned 10 90 38.8 36.6 37.7
50 50 24.9 65.1 36.1
Drug conditioned 10 90 13.6 83.5 23.4
50 50 9.4 95.1 17.0
Gene conditioned 10 90 19.0 75.3 30.3
50 50 9.5 90.1 17.3
Drug  Gene conditioned 10 90 21.6 64.9 32.4
50 50 11.0 85.6 19.5
Abstract Unconditioned 10 90 8.1 100.0 14.9
50 50 6.4 100.0 12.0
Drug–Gene conditioned 10 90 26.8 50.5 35.0
50 50 14.8 78.8 24.9
Drug conditioned 10 90 9.0 94.4 16.5
50 50 66.5 98.9 12.2
Gene conditioned 10 90 12.3 81.0 21.4
50 50 7.2 94.7 13.3
Drug  Gene conditioned 10 90 13.6 77.5 23.2
50 50 7.3 94.0 13.5
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drug–gene pairs; the drug–gene pairs do not necessarily all appear
in MEDLINE and are not necessarily valid PGx-speciﬁc drug–gene
pairs. The 29,862 drug–gene pairs comprise a superset of all valid
PGx-speciﬁc drug–gene pairs, including the 294 pairs derived from
PharmGKB.
As shown in Table 3, the F1 scores for the ‘‘Drug–Gene Condi-
tioned’’, ‘‘Gene Conditioned’’ and ‘‘Drug  Gene Conditioned’’ meth-
ods are similar (37.1% vs. 30.3% vs. 32.4%) when 10% of PharmGKB
data was used as training data set. When 50% of PharmGKB data
was used as training data set, the F1 score for the ‘‘Drug–Gene
Conditioned’’ method is signiﬁcantly higher than those for the
‘‘Gene Conditioned’’ and ‘‘Drug  Gene Conditioned’’ methods
(36.1% vs. 17.3% vs. 19.5%). The same trend holds true for drug–gene
extraction from abstracts. All three methods (‘‘Drug–Gene Condi-
tioned’’, ‘‘Gene Conditioned’’ and ‘‘Drug  Gene Conditioned’’) have
signiﬁcantly better precision and F1 values than the ‘‘Uncondi-
tioned’’ and ‘‘Drug Conditioned’’ methods. The ‘‘Unconditioned’’
and ‘‘Drug Conditioned’’ methods have similar F1 scores for drug–
gene relationship extraction from MEDLINE sentences (20.9% vs.
23.4% and 16.7 vs. 17.0) when 10% or 50% of PharmGKB data is used
as training data set. In summary, drug–gene relationship extrac-
tions from text documents (sentences or abstracts) containing
known PGx speciﬁc drug–gene pairs (‘‘Drug–Gene Conditioned’’),
gene terms (‘‘Gene Conditioned’’) or gene terms plus drug terms
(‘‘Drug  Gene Conditioned’’) have signiﬁcantly better precision
and F1 scores than methods based on unclassiﬁed documents
(‘‘Unconditioned’’) or documents containing additional drug names
from training dataset. The ‘‘Gene Conditioned’’ method performs as
well as both the ‘‘Drug–Gene Conditioned’’ and ‘‘Drug  Gene Con-
ditioned’’ methods, meaning that the appearance of a PGx-speciﬁc
gene symbol in a sentence is sufﬁcient to classify it as PGx-related.
For example, if a sentence contains a known PGx-speciﬁc gene sym-
bol ‘‘CYP2C9’’, it is likely that any drug–gene pairs extracted from
this sentence are PGx-speciﬁc. In addition, the occurrence of a
PGx-speciﬁc symbol such as ‘‘CYP2C9’’ in a sentence can implicitly
disambiguate other gene symbols in the same sentence. For exam-
ple, if the symbol ‘‘CAD’’ appears in a sentence containing the sym-
bol ‘‘CYP2C9’’, it is highly possible that ‘‘CAD’’ represents the
metabolizing gene ‘‘carbamoyl-phosphate synthetase 2, aspartate
transcarbamylase, and dihydroorotase’’, instead of the short name
for ‘‘coronary artery disease’’. On the other hand, occurrence of addi-
tional drug names from known drug–gene pairs cannot classify asentence as PGx-related or not. Drug terms can appear together
with ambiguous gene symbols such as ‘‘CAD’’ in sentences specify-
ing drug–disease relationships, or with gene symbols representing
drug–gene target relationships instead of drug–gene metabolizing
relationships.4.3. Detailed analysis of the mechanisms underlying the performance
improvements
We use speciﬁc examples to show how the ‘‘Drug–Gene Condi-
tioned’’ method can implicitly disambiguate gene symbols. We
picked six known ambiguous gene symbols (‘‘PC’’, ‘‘GC’’, ‘‘CP’’,
‘‘BID’’, ‘‘NP’’, and ‘‘CAD’’) based on our experience. For each of these
ambiguous gene symbols, we extracted the full gene names from
PharmGKB and non-gene-related names by searching MEDLINE.
As shown in the Table 4, the ‘‘Drug–Gene Conditioned’’ method
(column 5) signiﬁcantly reduces false positive rates compared to
the ‘‘Unconditioned’’ method (column 4). For example, total 506
different drug names co-occur with the symbol ‘‘PC’’ in MEDLINE.
However, more than 99% of the co-occurrences are not PGx-spe-
ciﬁc gene–drug pairs based on manual examination. The ‘‘Drug–
Gene Conditioned’’ method reduces the false positives from 506
to 33 for the symbol ‘‘PC’. Similar reductions are obtained for the
other ﬁve ambiguous gene symbols.
Next we show how the conditional method reduces false posi-
tive rates by examining some speciﬁc drug–gene pairs involving
ambiguous gene symbols. For example, the drug dipyridamole co-
occurred with the symbol ‘‘CAD’’ 334 times in MEDLINE; this pair
never appears together with known drug–gene pairs from Phar-
mGKB such as ‘‘warfarin-CYP2C9’’ (Table 5). The same is true for
the ambiguous symbol ‘‘GC’’. The symbol ‘‘GC’’ is highly ambigu-
ous; it refers to ‘‘glucose consumption’’, ‘‘glucose clearance’’,
‘‘glucose cycling’’, ‘‘glucose clamp’’, and ‘‘glucocorticoids’’. For exam-
ple, ‘‘GC’’ represents glucocorticoids in the sentence, ‘‘In the liver,
glucocorticoids (GC) normally regulates the glucose synthesis by acting
on PEPCK’’ (pmid17182006). The drug choline and symbol ‘‘GC’’
appear together in MEDLINE sentences 1126 times. However, the
pair choline-GC has not appeared together with any of the known
PGx drug–gene pairs. Since the ‘‘Drug–Gene Conditioned’’ method
only extracts drug–gene relationships from sentences containing
known PGx-speciﬁc drug–gene pairs, the pair dipyridamol-CAD or
choline-GC will be extracted.
Table 4
Comparison of ‘‘Unconditioned’’ and ‘‘Drug–Gene Conditioned’’ methods in gene disambiguation.
Gene symbol Gene name Alternative name
(Non-gene name)
False positives
(Unconditioned)
False positives
(Drug–Gene Conditioned)
PC Pyruvate carboxylase Phosphatidylcholine 506 33
GC Group-speciﬁc component Glucose consumption 482 30
CP Ceruloplasmin (ferroxidase) Cyclophosphamide 562 134
BID BH3 interacting domain death agonist Twice a day 315 18
NP Nucleoside phosphorylase Non-preferring 330 52
CAD Carbamoyl-phosphate synthetase Coronary artery disease 247 25
Table 5
Comparison of ‘‘Unconditioned’’ and ‘‘Drug–Gene Conditioned’’ methods in drug–
gene relationship extraction for ambiguous gene symbols ‘‘CAD’’ and ‘‘GC’’.
Symbol False positives
(Unconditioned)
False positives
(Drug–Gene Conditioned)
Dipyridamole CAD 334 0
Aspirin CAD 213 0
Atorvastatin CAD 87 0
Choline GC 1126 0
Ethanol GC 232 0
Paclitaxel GC 156 0
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We have developed four conditional methods (‘‘Drug–Gene
Conditioned’’, ‘‘Drug Conditioned’’, ‘‘Gene Conditioned’’ and
‘‘Drug  Gene Conditioned’’) for PGx-speciﬁc drug–gene relation-
ship extraction from MEDLINE. We have compared conditional
methods to an unconditioned method, which extracts drug–gene
pairs from unclassiﬁed sentences. We have shown that the
‘‘Drug–Gene Conditioned’’, ‘‘Gene Conditioned’’ and ‘‘Drug  Gene
Conditioned’’ methods signiﬁcantly improve precision and F1 mea-
sures, compared to both ‘‘Unconditioned’’ and ‘‘Drug Conditioned’’
methods in extracting PGx-speciﬁc drug–gene relationships from
MEDLINE. In this study, we used a co-occurrence based method
for drug–gene relationship extraction for its simplicity. However,
this co-occurrence based method can be replaced by more ad-
vanced relationship extraction methods such as machine learning
or NLP approaches.
Our approaches have a number of limitations. First, the preci-
sion of conditional methods largely depends on the precision of
the underlying prior knowledge. If there are incorrect or ambigu-
ous drug–gene pairs in the underlying knowledge base, the errors
and ambiguities will propagate into the extracted drug–gene pairs.
For example, in the sentence ‘‘At rest patients with CAD showed an
increased myocardial extraction of glutamate, glucose and lactate
and an augmented glutamine and alanine release compared with
controls’’ (PMID 02707269), CAD-glutamate is a disease–drug pair.
However, the same pair is also a PGx-speciﬁc drug–gene pair in
PharmGKB. Because of this ambiguous pair, our algorithm will
classify the above sentence as PGx-related. Three additional
drug-CAD pairs, namely CAD-glucose, CAD-lactate and CAD-alanine,
will be extracted as PGx-speciﬁc drug–gene pairs. In this situation,
the ‘‘Gene Conditioned’’ method will be able to classify this sen-
tence as non-PGx-related since it does not contain additional
PGx-speciﬁc genes. The ‘‘Gene Conditioned’’ method depends on
highly speciﬁc PGx-speciﬁc gene symbols. For example, the PGx-
speciﬁc gene symbol ‘‘CYP2C9’’ or ‘‘VKORC1’’ can disambiguate a
sentence as PGx-related or not. On the other hand, ambiguous gene
symbols such as ‘‘PC’’ or ‘‘GC’’ cannot. Therefore, to further improve
precision of conditional methods, we need to develop methods to
identify PGx-speciﬁc gene symbols or drug–gene pairs and only
use non-ambiguous gene symbols or pairs as the prior knowledge.An alternative approach would be to develop text classiﬁcation
methods to classify a sentence or abstract as PGx-related or non-
PGx-related based on text features such as the text patterns that
researchers use to describe PGx-speciﬁc drug–gene relationship.
The recall of the conditional methods depends on the coverage
of the underlying prior knowledge. Consider the sentence, ‘‘Oxato-
mide was metabolized by CYP2D6-Val and CYP3A4, but not by
CYP1A2, CYP2C9-Arg, CYP2C9-Cys or CYP2C19’’ (PMID 15133245).
The drug oxatomide does not associate with any genes in Phar-
mGKB. The ‘‘Drug–Gene Conditioned’’ algorithm will classify this
sentence as non-PGx-related since it does not contain any known
PGx-speciﬁc drug–gene pairs and will not extract the valid pairs
(CYP2D6-oxatomide and CYP3A4-oxatomide) from the sentence.
The ‘‘Unconditioned’’ method will extract these pairs, including
false positives (CYP1A2-oxatomide, CYP2C9-oxatomide, and
CYP2C19-oxatomide).
In this study, we used a co-occurrence based method as the
underlying drug–gene relationship extraction for conditional meth-
ods. The limitation of any co-occurrence approaches is that they
cannot differentiate pure co-occurrences from real semantic rela-
tionships. For example, in the sentence ‘‘In the present study, the pos-
sible role of genetic polymorphism of three drug-metabolizing enzymes,
debrisoquine/sparteine hydroxylase (CYP2D6), glutathione S-trans-
ferase mu (GSTM1), and N-acetyltransferase (NAT2), as a putative ge-
netic component of human longevity, was explored’’ (PMID 9654200),
there are three drugs (debrisoquine, sparteine, and glutathione) and
three drug metabolizing genes (CYP2D6, NAT2 and GSTM1). The
gene symbols ‘‘CYP2D6’’, ‘‘NAT2’’ and ‘‘GSTM1’’ are highly speciﬁc
drug metabolizing genes. In addition, the drug–gene pairs ‘‘debr-
isoquine-CYP2D6’’ and ‘‘sparteine-CYP2D6’’ pairs are in PharmGKB.
Our conditional methods (‘‘Drug–Gene Conditioned’’, ‘‘Gene Condi-
tioned’’ and ‘‘Drug  Gene Conditioned’’) will correctly classify this
sentence as PGx-related. The co-occurrence based relationship
extraction methods will extract nine (3  3) drug–gene relation-
ships (the same as the ‘‘Unconditioned’’), method instead of four
valid PGx-speciﬁc drug–gene pairs (debrisoquine-CYP2D6, sparteine-
CYP2D6, glutathione-GSTM1, and glutathione-NAT2). In this situation,
more advanced methods such as machine learning, NLP approaches,
or human curation will be still needed.
In summary, the performance of the conditional methods for
PGx-speciﬁc drug–gene relationship extraction depends on the
quality of the prior knowledge and the underlying relationship
extraction methods. Imprecision and ambiguity of prior knowledge
decrease the overall precision of conditional methods. The cover-
age of the prior knowledge can also affect the recall. In addition,
the underlying relationship extraction algorithms (co-occurrence,
machine learning, NLP, or rule-based approaches) will affect the
performance of the corresponding conditional methods. It will be
interesting to investigate how conditional prior knowledge can
affect other relationship extraction methods in PGx-speciﬁc
drug–gene relationship extraction. It may be possible that the
conditional methods only have a big impact on methods with
low precision such as the co-occurrence method, not on those with
high precision such as NLP or rule-based approaches.
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We have developed knowledge-driven conditional relationship
extraction approaches to extract PGx-speciﬁc drug–gene pairs
from 20 million MEDLINE abstracts. We have used the drug–gene
pairs available in PharmGKB as prior knowledge to implicitly clas-
sify sentences before applying relationship extraction methods.
The conditional methods signiﬁcantly improve both the precision
and F1 measures compared to the traditional (unconditioned)
method (precision: 0.345 vs. 0.11; recall: 0.481 vs. 1.00; F1:
0.402 vs. 0.201). Our method is not limited to PGx-speciﬁc drug–
gene relationship extraction, and it can be generalized to extract
other types of biomedical relationships from free text, provided
that high quality prior background knowledge exists for a give task.
In the future, we will develop automatic approaches to identify
ambiguous gene and drug–gene pairs from PharmGKB, to further
improve the precision of prior knowledge and of the conditional
methods. In addition, we will develop conditional PGx-speciﬁc
drug–gene extraction methods based on more advanced relation-
ship extraction methods such as NLP approaches.
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